Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-26-197828
Filing Date
2026-04-30
Accepted
2026-04-30 17:13:23
Documents
15
Effectiveness Date
2026-04-30

Document Format Files

Seq Description Document Type Size
1 S-1MEF d133636ds1mef.htm S-1MEF 28215
2 EX-5.1 d133636dex51.htm EX-5.1 8622
3 EX-23.1 d133636dex231.htm EX-23.1 1851
4 EX-FILING FEES d133636dexfilingfees.htm   iXBRL EX-FILING FEES 17875
5 GRAPHIC g133636g61j96.jpg GRAPHIC 2856
6 GRAPHIC g133636g80k66.jpg GRAPHIC 9827
  Complete submission text file 0001193125-26-197828.txt   197857

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT d133636dexfilingfees_htm.xml XML 4740
Mailing Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1220 CAMBRIDGE MA 02142 45 2138 7627
Hemab Therapeutics Holdings, Inc. (Filer) CIK: 0002114044 (see all company filings)

EIN.: 414241952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-295466 | Film No.: 26927187
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)